Spinal Intervention: Markets for Surgical, Replacement and Neurostimulation Technologies
The global market for spinal and neurostimulation intervention products is expected to reach $15.8 billion by 2021 from $12.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 4.5% from 2016 through 2021.
- An overview of the global markets for surgical, replacement, and neurostimulation technologies as they relate to spinal intervention.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of several types of surgical procedure currently available for the treatment of spinal diseases and injury, including spinal fusion, disc replacement, facet replacement and kyphoplasty, all of which use different products and technologies, and have different advantages and drawbacks.
- Analyses of the market in terms of key product and technology areas, major manufacturers and factors influencing market growth and demand.
- Key corporate activities, including such a mergers & acquisitions, strategic alliances and research & development.
- Profiles of major players in the industry.
SCOPE OF REPORT
The report provides an analysis of the markets for spinal and neurostimulation products, including trends and sales to 2021. It analyzes the market in terms of key product and technology areas, major manufacturers and factors influencing market growth.
Manufacturers of neurostimulation and spinal technologies are discussed and analyzed based on product types, market share and key corporate activities, including a mergers and acquisitions, strategic alliances, and research and development. In addition to neurostimulation products used for the treatment of spinal conditions, the report looks at the wider neurostimulation industry in order to provide a more comprehensive analysis of the overall market and growth opportunities for companies operating in this field.
The report also includes an in-depth analysis of new products and technologies in development, as well as the development of new products that can address a growing number of therapeutic indications.
Excluded from the scope of the report are spinal soft goods, bracing products and externally worn neurostimulation devices.
Joanne Maddox is an experienced healthcare industry analyst specializing on the medical device and diagnostics markets. She has 16 years of experience working specifically in this niche area. Her work has included competitor and market insight, due diligence assistance, market forecasting and trend analysis of the medical devices industry, with a key focus on orthopedic and spinal technologies, implantable electronic devices, diagnostics, medical imaging and wound care.